Cargando…

Therapy of Non-Dermatophytic Mycoses in Animals

This review focuses on aspects of antimycotic therapy specific to veterinary medicine. In the first part, drug availability, limited mostly by economic consideration but also by clinical applicability and specific adverse effects, is described for polyenes, 5 fluorocytosine, azoles, echinocandins an...

Descripción completa

Detalles Bibliográficos
Autor principal: Elad, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308939/
https://www.ncbi.nlm.nih.gov/pubmed/30380772
http://dx.doi.org/10.3390/jof4040120
_version_ 1783383306046275584
author Elad, Daniel
author_facet Elad, Daniel
author_sort Elad, Daniel
collection PubMed
description This review focuses on aspects of antimycotic therapy specific to veterinary medicine. In the first part, drug availability, limited mostly by economic consideration but also by clinical applicability and specific adverse effects, is described for polyenes, 5 fluorocytosine, azoles, echinocandins and terbinafine. In the second part, current knowledge and experience in the treatment of selected fungal infections are overviewed. These mycoses include disseminated mold infections in small animals (dogs and cats) and avian species, upper respiratory tract infections of small animals (sino-nasal and sino-orbital aspergillosis) and horses (guttural pouch mycosis), eumycetoma, infections caused by dimorphic fungi, (blastomycosis, histoplasmosis, coccidioidomycosis, paracoccidioidomycosis and sporothrichosis) and by yeasts and yeast-like microorganism (Cryptococcus spp. and Malassezia pachydermatis).
format Online
Article
Text
id pubmed-6308939
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63089392019-06-17 Therapy of Non-Dermatophytic Mycoses in Animals Elad, Daniel J Fungi (Basel) Review This review focuses on aspects of antimycotic therapy specific to veterinary medicine. In the first part, drug availability, limited mostly by economic consideration but also by clinical applicability and specific adverse effects, is described for polyenes, 5 fluorocytosine, azoles, echinocandins and terbinafine. In the second part, current knowledge and experience in the treatment of selected fungal infections are overviewed. These mycoses include disseminated mold infections in small animals (dogs and cats) and avian species, upper respiratory tract infections of small animals (sino-nasal and sino-orbital aspergillosis) and horses (guttural pouch mycosis), eumycetoma, infections caused by dimorphic fungi, (blastomycosis, histoplasmosis, coccidioidomycosis, paracoccidioidomycosis and sporothrichosis) and by yeasts and yeast-like microorganism (Cryptococcus spp. and Malassezia pachydermatis). MDPI 2018-10-30 /pmc/articles/PMC6308939/ /pubmed/30380772 http://dx.doi.org/10.3390/jof4040120 Text en © 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Elad, Daniel
Therapy of Non-Dermatophytic Mycoses in Animals
title Therapy of Non-Dermatophytic Mycoses in Animals
title_full Therapy of Non-Dermatophytic Mycoses in Animals
title_fullStr Therapy of Non-Dermatophytic Mycoses in Animals
title_full_unstemmed Therapy of Non-Dermatophytic Mycoses in Animals
title_short Therapy of Non-Dermatophytic Mycoses in Animals
title_sort therapy of non-dermatophytic mycoses in animals
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308939/
https://www.ncbi.nlm.nih.gov/pubmed/30380772
http://dx.doi.org/10.3390/jof4040120
work_keys_str_mv AT eladdaniel therapyofnondermatophyticmycosesinanimals